Literature DB >> 27179451

Converging advances in science, policy and public awareness: A time of great opportunity and change in addiction treatment.

Abigail Mason Woodworth1, A Thomas McLellan2.   

Abstract

Scientific advances, increased public awareness about addiction as a disease, and significant changes in public policy have led to transformational changes in this field. Preclinical and clinical studies highlighted in this issue have supported the emerging concept of substance use disorders as a novel major concern within the healthcare community. In this Commentary, we discuss the potential impact of recent legislation (Affordable Care Act and the Mental Health Parity and Addiction Equity Act) when fully implemented to end the real and perceived segregation of addiction and substance abuse disorders from mainstream healthcare and insurance reimbursement. These legislative changes, along with the diligence of public interest and scientific advances, have the potential to move prevention and treatment of substance use disorders to mainstream healthcare, and to educate professionals appropriately on the prevention and treatment of substance abuse.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Addiction Equity; Affordable Care Act; Parity Act; Substance use disorders

Mesh:

Year:  2016        PMID: 27179451     DOI: 10.1016/j.brainresbull.2016.05.005

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

Review 1.  Posttraumatic Stress Disorder and Alcohol Use Disorder: A Critical Review of Pharmacologic Treatments.

Authors:  Ismene L Petrakis; Tracy L Simpson
Journal:  Alcohol Clin Exp Res       Date:  2017-01-19       Impact factor: 3.455

2.  Addiction: A preclinical and clinical analysis.

Authors:  Patricia Sue Grigson
Journal:  Brain Res Bull       Date:  2016-03-19       Impact factor: 4.077

3.  Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients.

Authors:  Kristin L Serowik; Kimberly A Yonkers; Kathryn Gilstad-Hayden; Ariadna Forray; Paula Zimbrean; Steve Martino
Journal:  J Gen Intern Med       Date:  2020-10-27       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.